Catalyst

Slingshot members are tracking this event:

Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TEVA

100%

Additional Information

http://www.businessw...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 22, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sd-809, Tardive Dyskinesia, Aim-td Trial